Hydroxychloroquine is not recommended as a treatment for coronavirus
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ)
The American Red Cross wants to remind the public that receiving a COVID
A new
Hydroxychloroquine (HCQ) is a 4-aminoquinoline that differs by the
The scientific community should consider this information in light of previous experiments with ch
The antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have shown promising potential in clinical setups to combat COVID-19
Drugs used for other diseases were tried out in COVID‐19, and this included chloroquine, used for malaria; and hydroxychloroquine used for rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus
Chloroquine has been proposed several times for the treatment of acute viral diseases in humans without success
It is also used to treat liver infection caused by protozoa (extraintestinal amebiasis)
Political leaders have touted their use and recommended availability to the public
Common side effects of
On the other hand, COVID‐19 resulted in several hundred thousand deaths since December 2019 and remains without an efficient and safe treatment
The authors sought evidence of the effects of these drugs in treating people ill with the disease; in preventing the disease In February, researchers showed that chloroquine could reduce coronavirus infection of human cells grown in the laboratory 1
Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection
Commonly used antimalarial drugs can be divided into different classes on the basis of their core structure
Several existing drugs
At least 60 kg: 1 g salt (600 mg base) orally as an initial dose, followed by 500 mg salt (300 mg base) orally after 6 to 8 hours In the past six weeks, Dr